Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)
China
· Delayed Price · Currency is CNY 14.02
+0.03 (0.21%)
Mar 10, 2026, 3:00 PM CST
SHA:600557 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 7,938 | 7,756 | 11,999 | 10,961 | 7,055 | 6,030 | Upgrade
|
| Market Cap Growth | 1.97% | -35.36% | 9.47% | 55.36% | 17.01% | -31.00% | Upgrade
|
| Enterprise Value | 5,982 | 5,802 | 9,984 | 9,682 | 6,533 | 5,967 | Upgrade
|
| Last Close Price | 14.02 | 13.62 | 20.09 | 18.13 | 11.84 | 9.83 | Upgrade
|
| PE Ratio | 28.57 | 19.79 | 25.85 | 25.23 | 22.01 | 22.93 | Upgrade
|
| Forward PE | 18.33 | 12.25 | 19.80 | 22.32 | 12.64 | 11.64 | Upgrade
|
| PS Ratio | 2.53 | 1.99 | 2.47 | 2.52 | 1.93 | 1.99 | Upgrade
|
| PB Ratio | 1.62 | 1.65 | 2.39 | 2.22 | 1.58 | 1.39 | Upgrade
|
| P/TBV Ratio | 1.78 | 1.81 | 2.56 | 2.46 | 1.78 | 1.60 | Upgrade
|
| P/FCF Ratio | - | 34.35 | 18.15 | 13.97 | 9.58 | 11.81 | Upgrade
|
| P/OCF Ratio | 16.55 | 11.04 | 12.34 | 11.01 | 7.77 | 8.60 | Upgrade
|
| PEG Ratio | - | 1.80 | 1.80 | 1.80 | 1.80 | 1.80 | Upgrade
|
| EV/Sales Ratio | 1.91 | 1.49 | 2.05 | 2.23 | 1.79 | 1.97 | Upgrade
|
| EV/EBITDA Ratio | 15.24 | 11.93 | 16.52 | 16.44 | 12.88 | 11.24 | Upgrade
|
| EV/EBIT Ratio | 30.68 | 20.01 | 24.37 | 24.27 | 20.41 | 16.07 | Upgrade
|
| EV/FCF Ratio | -282.00 | 25.69 | 15.10 | 12.34 | 8.87 | 11.68 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0 | 0 | 0 | 0.05 | 0.11 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.47 | 0.92 | Upgrade
|
| Debt / FCF Ratio | - | 0.01 | 0.00 | 0.00 | 0.32 | 0.96 | Upgrade
|
| Net Debt / Equity Ratio | -0.44 | -0.47 | -0.49 | -0.36 | -0.20 | -0.06 | Upgrade
|
| Net Debt / EBITDA Ratio | -5.49 | -4.59 | -4.03 | -3.00 | -1.73 | -0.53 | Upgrade
|
| Net Debt / FCF Ratio | 101.57 | -9.89 | -3.69 | -2.25 | -1.19 | -0.56 | Upgrade
|
| Asset Turnover | 0.46 | 0.55 | 0.70 | 0.68 | 0.60 | 0.50 | Upgrade
|
| Inventory Turnover | 1.98 | 2.39 | 3.62 | 3.57 | 2.87 | 2.52 | Upgrade
|
| Quick Ratio | 1.69 | 1.44 | 1.73 | 1.83 | 1.70 | 1.41 | Upgrade
|
| Current Ratio | 2.00 | 1.76 | 2.00 | 2.09 | 1.98 | 1.70 | Upgrade
|
| Return on Equity (ROE) | 5.68% | 7.83% | 8.92% | 9.40% | 7.37% | 6.51% | Upgrade
|
| Return on Assets (ROA) | 1.79% | 2.57% | 3.66% | 3.89% | 3.30% | 3.80% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.05% | 11.36% | 14.13% | 11.70% | 8.28% | 8.22% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.80% | 6.00% | 8.00% | 8.00% | 7.00% | 8.40% | Upgrade
|
| Earnings Yield | 3.54% | 5.05% | 3.87% | 3.96% | 4.54% | 4.36% | Upgrade
|
| FCF Yield | -0.27% | 2.91% | 5.51% | 7.16% | 10.44% | 8.47% | Upgrade
|
| Dividend Yield | - | - | 1.85% | 1.21% | - | - | Upgrade
|
| Payout Ratio | - | 54.50% | 27.69% | 0.57% | 3.45% | 26.02% | Upgrade
|
| Buyback Yield / Dilution | 0.12% | 0.68% | -0.16% | -1.20% | 4.21% | -1.36% | Upgrade
|
| Total Shareholder Return | 0.12% | 0.68% | 1.70% | 0.01% | 4.21% | -1.36% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.